Compare DERM & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DERM | LFCR |
|---|---|---|
| Founded | 2014 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 267.4M | 269.8M |
| IPO Year | 2021 | 1996 |
| Metric | DERM | LFCR |
|---|---|---|
| Price | $8.19 | $6.91 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $12.67 | N/A |
| AVG Volume (30 Days) | 98.1K | ★ 100.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $56,134,000.00 | ★ $557,559,000.00 |
| Revenue This Year | $17.48 | $2.80 |
| Revenue Next Year | $55.83 | $11.51 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $4.99 | $4.76 |
| 52 Week High | $9.56 | $8.98 |
| Indicator | DERM | LFCR |
|---|---|---|
| Relative Strength Index (RSI) | 49.49 | 34.30 |
| Support Level | $6.92 | $6.60 |
| Resistance Level | $8.71 | $7.03 |
| Average True Range (ATR) | 0.43 | 0.30 |
| MACD | -0.05 | -0.00 |
| Stochastic Oscillator | 36.20 | 40.82 |
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.